The success of this company seems to hinge on getting "ACIP preferred recommendation".
The vaccine seems to be very expensive and difficult to manufacture. $102,000,000 gone in the year before they even started a phase 1 trial. Seems very expensive and too hard to manufacture.
Are there other companies with conjugate vaccines just as good?
Market Data 
Markets 
AI
